300 related articles for article (PubMed ID: 18274840)
21. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
23. Pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Sasaki T
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S84-8. PubMed ID: 19896105
[TBL] [Abstract][Full Text] [Related]
24. Pancreaticobiliary maljunction and biliary cancer.
Kamisawa T; Kuruma S; Tabata T; Chiba K; Iwasaki S; Koizumi S; Kurata M; Honda G; Itoi T
J Gastroenterol; 2015 Mar; 50(3):273-9. PubMed ID: 25404143
[TBL] [Abstract][Full Text] [Related]
25. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.
Aishima S; Kubo Y; Tanaka Y; Oda Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):448-52. PubMed ID: 24446428
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
27. Recent advances and problems in the management of pancreaticobiliary maljunction: feedback from the guidelines committee.
Kamisawa T; Ando H; Shimada M; Hamada Y; Itoi T; Takayashiki T; Miyazaki M
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):87-92. PubMed ID: 23798483
[TBL] [Abstract][Full Text] [Related]
28. Cancer of the gallbladder associated with pancreaticobiliary maljunction without bile duct dilatation in a european patient.
Tuech JJ; Pessaux P; Aube C; Regenet N; Cervi C; Bergamaschi R; Arnaud JP
J Hepatobiliary Pancreat Surg; 2000; 7(3):336-8. PubMed ID: 10982637
[TBL] [Abstract][Full Text] [Related]
29. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
30. [Surgical treatment of cancer of the biliary tract and gall bladder].
Nakayama T; Shimada S; Kinoshita H; Kosuga K
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1264-8. PubMed ID: 2069396
[TBL] [Abstract][Full Text] [Related]
31. Pathological features and surgical outcome of pancreaticobiliary maljunction without dilatation of the extrahepatic bile duct.
Tsuchida A; Itoi T; Endo M; Kitamura K; Mukaide M; Itokawa F; Ozawa T; Aoki T
Oncol Rep; 2004 Feb; 11(2):269-76. PubMed ID: 14719053
[TBL] [Abstract][Full Text] [Related]
32. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.
Tsuchida A; Itoi T
World J Gastrointest Oncol; 2010 Mar; 2(3):130-5. PubMed ID: 21160820
[TBL] [Abstract][Full Text] [Related]
33. Bile ductal mucosal dysplasia is a possible risk factor for adenocarcinoma in patients with adenomyomatous hyperplasia of the Vaterian system: a single-centre study from China.
Liu W; Li J; Yang Z; Jiang J; Zhang D; Lu W
BMC Gastroenterol; 2024 Jan; 24(1):8. PubMed ID: 38166823
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study.
Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y
Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194
[TBL] [Abstract][Full Text] [Related]
35. Imaging Features of Premalignant Biliary Lesions and Predisposing Conditions with Pathologic Correlation.
Zulfiqar M; Chatterjee D; Yoneda N; Hoegger MJ; Ronot M; Hecht EM; Bastati N; Ba-Ssalamah A; Bashir MR; Fowler K
Radiographics; 2022; 42(5):1320-1337. PubMed ID: 35930475
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
37. Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.
Niiyama H; Mizumoto K; Kusumoto M; Ogawa T; Suehara N; Shimura H; Tanaka M
Cancer; 1999 May; 85(10):2138-43. PubMed ID: 10326691
[TBL] [Abstract][Full Text] [Related]
38. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
39. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
Hou L; Xu J; Gao YT; Rashid A; Zheng SL; Sakoda LC; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Meyers DA; Fraumeni JF; Hsing AW
Int J Cancer; 2006 Jun; 118(11):2847-53. PubMed ID: 16381022
[TBL] [Abstract][Full Text] [Related]
40. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.
Hsing AW; Bai Y; Andreotti G; Rashid A; Deng J; Chen J; Goldstein AM; Han TQ; Shen MC; Fraumeni JF; Gao YT
Int J Cancer; 2007 Aug; 121(4):832-8. PubMed ID: 17450525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
